A cross-talk between Bmp7 and Tgf-β  signaling in the regulation of EMT in breast cancer is proposed, and Bmp7 was identified as a potential key molecule in therapy for metastatic bone disease [11]. This evidence concerns the gene BMP7 and breast cancer.